Global Inhaled Nitric Oxide market will reach 1489.5 million US$ by the end of 2025

Publisher: QYResearch

Published Date: 2019/11/13

The Global Inhaled Nitric Oxide market size was 847.7 million USD in 2018 and it will be 1489.5 million USD in 2025, with a CAGR of 8.39% from 2018 to 2025. The Inhaled Nitric Oxide market is growing rapidly in accordance with the growth in the medical gas market. Inhaled NO therapy is commonly used in intensive care units to treat patients with adult respiratory distress syndrome (ARDS), and it appears that inhaled NO is effective in treating conditions that result in pulmonary hypertension, such as, persistent pulmonary hypertension of the neonate (PPHN), and in diseases characterized by disturbances in gas exchange, such as chronic obstructive pulmonary disease (COPD).

The market is highly concentrated, with high technical and professional level. Key vendors in this market are Mallinckrodt, Praxair and Air Liquide, they are taking up to 91.329% market share in 2018. Inhaled Nitric Oxide types commonly used in this market are 800 ppm and 100 ppm, small players tend to produce lower purity products, such as 1000 ppm or so.

According to the research, North America and Europe comprised the biggest consumption areas. Other markets like Japan and China are growing relatively slow.

Though the gross margin is high, but with complex production process and acquisition between enterprises, we tend to believe that this market is going to keep the monopoly status in the forecast period.

Click to view the full report: https://www.qyresearch.com/index/detail/709802/global-inhaled-nitric-oxide-industry

This article was first released by QYResearch, if reproduced, please indicate the source.

Marketing: sales@qyresearchglobal.com

Media Contact: press@qyresearch.com